Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 01, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Rosetta Genomics Announces NGS Research Collaboration with Weizmann Institute
Friday, August 01, 2014
Developing novel methods for next-generation sequencing of small RNAs.

UTSW Cancer Researchers Identify Irreversible Inhibitor for KRAS Gene Mutation
Tuesday, July 29, 2014
Irreversible inhibitor for KRAS gene mutation involved in lung, colon, and pancreatic cancers.

QIAGEN, AstraZeneca to Develop Liquid Biopsy-based Companion Diagnostic
Monday, July 28, 2014
The collaboration is to advance EGFR mutation profiling in lung cancer patients.

QIAGEN Licenses Blood Cancer Biomarkers
Saturday, July 26, 2014
Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including NGS gene panels, for blood cancers.

Alnylam Receives Notice of Allowance from USPTO
Saturday, July 26, 2014
Allowed claims of Manoharan '478 application cover GalNAc-conjugates independent of length, sequence, and disease target.

Rosetta Genomics Receives Final New York State Approval
Saturday, July 26, 2014
Proprietary microRNA diagnostic for identification of four major subtypes of kidney cancer now available in all 50 U.S. states.

Horizon and OPDC Sign Collaboration Agreement
Friday, July 25, 2014
Horizon CombinatoRx to perform in-vitro cell line screening of OPDC clinical stage development candidates.

Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold
Thursday, July 24, 2014
All other clinical development programs on track.

CRELUX and 4SC Discovery Awarded Research Grant
Thursday, July 24, 2014
Project for identifying new bromodomain inhibitors initiated under the Munich m4 biotech cluster programme.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 3055
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv